» Articles » PMID: 33523981

ITIH4 Acts As a Protease Inhibitor by a Novel Inhibitory Mechanism

Overview
Journal Sci Adv
Specialties Biology
Science
Date 2021 Feb 1
PMID 33523981
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Inter-α-inhibitor heavy chain 4 (ITIH4) is a poorly characterized plasma protein that is proteolytically processed in multiple pathological conditions. However, no biological function of ITIH4 has been identified. Here, we show that ITIH4 is cleaved by several human proteases within a protease-susceptible region, enabling ITIH4 to function as a protease inhibitor. This is exemplified by its inhibition of mannan-binding lectin-associated serine protease-1 (MASP-1), MASP-2, and plasma kallikrein, which are key proteases for intravascular host defense. Mechanistically, ITIH4 acts as bait that, upon cleavage, forms a noncovalent, inhibitory complex with the executing protease that depends on the ITIH4 von Willebrand factor A domain. ITIH4 inhibits the MASPs by sterically preventing larger protein substrates from accessing their active sites, which remain accessible and fully functional toward small substrates. Thus, we demonstrate that ITIH4 functions as a protease inhibitor by a previously undescribed inhibitory mechanism.

Citing Articles

Infectious parvovirus B19 circulates in the blood coated with active host protease inhibitors.

Lee H, Assaraf R, Subramanian S, Goetschius D, Bieri J, DiNunno N Nat Commun. 2024; 15(1):9543.

PMID: 39500886 PMC: 11538491. DOI: 10.1038/s41467-024-53794-1.


Unraveling the impact of different liposomal formulations on the plasma protein corona composition might give hints on the targeting capability of nanoparticles.

Imperlini E, Di Marzio L, Cevenini A, Costanzo M, dAvanzo N, Fresta M Nanoscale Adv. 2024; 6(17):4434-4449.

PMID: 39170967 PMC: 11334990. DOI: 10.1039/d4na00345d.


Development of DNA Insertion-specific Markers Based on the Intron Region of Oplegnathus punctatus itih4b for Genetic Sex Identification.

Ma Y, Xiao Y, Xiao Z, Li J Mar Biotechnol (NY). 2024; 26(6):1120-1128.

PMID: 39136869 DOI: 10.1007/s10126-024-10359-z.


ITIH4 is a predictor for coronary thrombus in coronary arteriography patients.

Tian L, Zhao S, Zhang R Future Cardiol. 2024; 20(10):547-554.

PMID: 39041488 PMC: 11485701. DOI: 10.1080/14796678.2024.2377924.


Linkage of serum ITIH4 with Th2 signature cytokine, inflammation, exacerbation risk and severity in childhood asthma.

Li W, Wang X, An H Biomark Med. 2024; 18(13-14):593-602.

PMID: 39011671 PMC: 11370966. DOI: 10.1080/17520363.2024.2366149.


References
1.
Kim M, Gu B, Song S, Choi B, Cha D, Baek K . ITI-H4, as a biomarker in the serum of recurrent pregnancy loss (RPL) patients. Mol Biosyst. 2011; 7(5):1430-40. DOI: 10.1039/c0mb00219d. View

2.
Rappsilber J, Mann M, Ishihama Y . Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc. 2007; 2(8):1896-906. DOI: 10.1038/nprot.2007.261. View

3.
Parej K, Dobo J, Zavodszky P, Gal P . The control of the complement lectin pathway activation revisited: both C1-inhibitor and antithrombin are likely physiological inhibitors, while α2-macroglobulin is not. Mol Immunol. 2013; 54(3-4):415-22. DOI: 10.1016/j.molimm.2013.01.009. View

4.
Gialeli C, Theocharis A, Karamanos N . Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 2010; 278(1):16-27. DOI: 10.1111/j.1742-4658.2010.07919.x. View

5.
Degn S, Jensen L, Gal P, Dobo J, Holmvad S, Jensenius J . Biological variations of MASP-3 and MAp44, two splice products of the MASP1 gene involved in regulation of the complement system. J Immunol Methods. 2010; 361(1-2):37-50. DOI: 10.1016/j.jim.2010.07.006. View